Extremely significant negative changes in Vanda Pharmaceuticals Inc (NASDAQ: VNDA) investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, the stock fell on very heavy volume, and negative upside/downside volume developed.
Slight negative changes in Vanda Pharmaceuticals Inc (NASDAQ: VNDA) fundamentals have recently occurred: significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of A. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, VNDA is expected to be Value Creation neutral.
Vanda Pharmaceuticals has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Vanda Pharmaceuticals has a good Appreciation Score of 70 and a very high Power Rating of 85, leading to the Highest Value Trend Rating.
Recent Price Action
On 9/19/24, Vanda Pharmaceuticals Inc (NASDAQ: VNDA) stock suffered a large decline of -6.1%, closing at $4.65. Moreover, this decline was accompanied by exceptionally high trading volume at 308% of normal. Relative to the market the stock has been exceptionally strong over the last nine months but has declined -5.5% during the last week.
Be the first to comment